文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

保护性通气与COVID-19重症患者的结局:一项队列研究

Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study.
PubMed 文献 · Ann Intensive Care · 2021-06-07
一句话结论在COVID-19重症患者中,保护性通气与28天生存独立相关(aHR 0.73,95%CI 0.57-0.94),调整PF比值、肺顺应性、PEEP和动脉血pH后仍显著。

该队列纳入巴西圣保罗最大的COVID-19转诊中心2020年3月30日至6月30日期间收入ICU的1503例COVID-19患者,主要终点为28天生存。随访28天内1180例(79%)需要侵入性通气,666例(44%)死亡。在ICU最初24小时内接受机械通气的984例患者中,平均潮气量为理想体重6.5±1.3 mL/kg,平台压24±5 cmH2O,呼吸系统顺应性31.9(24.4-40.9)mL/cmH2O,82%的患者接受保护性通气。多变量Cox模型显示保护性通气与生存独立相关(aHR 0.73,95%CI 0.57-0.94)。

要点

  • 在ICU最初24小时内接受机械通气的984例COVID-19患者中,82%接受保护性通气,平均潮气量为理想体重6.5±1.3 mL/kg。
  • 多变量Cox模型调整PF比值、肺顺应性、PEEP和动脉血pH后,保护性通气与28天生存独立相关(aHR 0.73,95%CI 0.57-0.94)。
  • 1503例患者中1180例(79%)在28天随访期间需要侵入性通气,666例(44%)死亡。
  • 984例机械通气患者平台压为24±5 cmH2O,呼吸系统顺应性为31.9(24.4-40.9)mL/cmH2O;顺应性与生存相关,未显示支持两种表型存在的双峰模式。
  • 非侵入性通气用于21%的患者,俯卧位用于36%的患者。

适用人群与场景

  • 2020年3月30日至6月30日收入巴西圣保罗一家学术医院ICU的COVID-19患者,该院有94张ICU床位,疫情期间作为州应急计划的一部分扩展至300张。

处置流程与药物剂量

  • 在ICU最初24小时内接受机械通气的984例患者中,82%接受保护性通气,平均潮气量为理想体重6.5±1.3 mL/kg,平台压24±5 cmH2O。
  • 非侵入性通气用于21%的患者,俯卧位用于36%的患者。

研究设计与关键结果

  • 该队列纳入1503例患者,平均年龄60±15岁,59%为男性;28天随访期间1180例(79%)需要侵入性通气,666例(44%)死亡。
  • 在ICU最初24小时内接受机械通气的984例患者中,平均潮气量为理想体重6.5±1.3 mL/kg,平台压24±5 cmH2O,呼吸系统顺应性31.9(24.4-40.9)mL/cmH2O,82%的患者接受保护性通气。
  • 顺应性与生存相关,未显示支持两种表型存在的双峰模式。
  • 多变量Cox模型调整PF比值、肺顺应性、PEEP和动脉血pH后,保护性通气与生存独立相关(aHR 0.73,95%CI 0.57-0.94)。
  • 非侵入性通气用于21%的患者,俯卧位用于36%的患者。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究结果揭示了机械通气策略与死亡率之间的关联,强调了对COVID-19患者实施保护性通气的重要性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Approximately 5% of COVID-19 patients develop respiratory failure and need ventilatory support, yet little is known about the impact of mechanical ventilation strategy in COVID-19. Our objective was to describe baseline characteristics, ventilatory parameters, and outcomes of critically ill patients in the largest referral center for COVID-19 in Sao Paulo, Brazil, during the first surge of the pandemic.

METHODS: This cohort included COVID-19 patients admitted to the intensive care units (ICUs) of an academic hospital with 94 ICU beds, a number expanded to 300 during the pandemic as part of a state preparedness plan. Data included demographics, advanced life support therapies, and ventilator parameters. The main outcome was 28-day survival. We used a multivariate Cox model to test the association between protective ventilation and survival, adjusting for PF ratio, pH, compliance, and PEEP.

RESULTS: We included 1503 patients from March 30 to June 30, 2020. The mean age was 60 ± 15 years, and 59% were male. During 28-day follow-up, 1180 (79%) patients needed invasive ventilation and 666 (44%) died. For the 984 patients who were receiving mechanical ventilation in the first 24 h of ICU stay, mean tidal volume was 6.5 ± 1.3 mL/kg of ideal body weight, plateau pressure was 24 ± 5 cmH2O, respiratory system compliance was 31.9 (24.4-40.9) mL/cmH2O, and 82% of patients were ventilated with protective ventilation. Noninvasive ventilation was used in 21% of patients, and prone, in 36%. Compliance was associated with survival and did not show a bimodal pattern that would support the presence of two phenotypes. In the multivariable model, protective ventilation (aHR 0.73 [95%CI 0.57-0.94]), adjusted for PF ratio, compliance, PEEP, and arterial pH, was independently associated with survival.

CONCLUSIONS: During the peak of the epidemic in Sao Paulo, critically ill patients with COVID-19 often required mechanical ventilation and mortality was high. Our findings revealed an association between mechanical ventilation strategy and mortality, highlighting the importance of protective ventilation for patients with COVID-19.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Ferreira JC, Ho YL, Besen BAMP, et al. Protective ventilation and outcomes of critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021. PMID: 34097145. doi:10.1186/s13613-021-00882-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。